User:Andre Wu Le Chun/Sandbox 1: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 40: | Line 40: | ||
<references/> | <references/> | ||
Hoffmann, Markus & Kleine-Weber, Hannah & Schroeder, Simon & Krüger, Nadine & Herrler, Tanja & Erichsen, Sandra & Schiergens, Tobias & Herrler, Georg & Wu, Nai-Huei & Nitsche, Andreas & Müller, Marcel & Drosten, Christian & Pöhlmann, Stefan. (2020). SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 181. 10.1016/j.cell.2020.02.052. | Hoffmann, Markus & Kleine-Weber, Hannah & Schroeder, Simon & Krüger, Nadine & Herrler, Tanja & Erichsen, Sandra & Schiergens, Tobias & Herrler, Georg & Wu, Nai-Huei & Nitsche, Andreas & Müller, Marcel & Drosten, Christian & | ||
Pöhlmann, Stefan. (2020). SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 181. 10.1016/j.cell.2020.02.052. | |||
Tortorici, M. Alejandra & Veesler, David. (2019). Structural insights into coronavirus entry. 10.1016/bs.aivir.2019.08.002. | Tortorici, M. Alejandra & Veesler, David. (2019). Structural insights into coronavirus entry. 10.1016/bs.aivir.2019.08.002. | ||
Walls, Alexandra & Park, Young-Jun & Tortorici, M. & Wall, Abigail & Mcguire, Andrew & Veesler, David. (2020). Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein. 10.1101/2020.02.19.956581. | |||
